Safety:
CoQ10 is generally safe up to 1,200 mg/day. Some people report mild digestive upset. It should be taken with food containing fat for better absorption. Patients on warfarin should be cautious, as CoQ10 can interfere with its effect.
Nicotinamide Riboside (NR)
What It Is:
NR is a form of vitamin B3 that acts as a direct precursor to NAD⁺, a molecule required for hundreds of metabolic processes. NAD⁺ levels decline with age, making this pathway a major focus in longevity research.
Quick Facts Callout:
Details:
NR is a vitamin B3 derivative that bypasses bottlenecks in NAD⁺ synthesis. Evidence shows reliable increases in NAD⁺ levels, with some studies noting cardiovascular benefits. Results for insulin sensitivity are mixed. NR is better studied than NMN in humans and holds GRAS status. Typical dosing is 300–2,000 mg/day.
What the Evidence Says:
NR vs NMN:
NMN is another NAD⁺ booster that has gained attention, but it must be converted into NR before entering cells. NR is considered more direct and has stronger safety data at this time.
Safety:
Most people tolerate NR well. GI discomfort is the most common side effect. Typical trial doses range from 300 to 2,000 mg/day.
Fisetin
What It Is:
Fisetin is a flavonoid found in fruits and vegetables. It has antioxidant and anti-inflammatory properties and has been studied for its ability to target senescent cells, earning it the label “senolytic candidate.”
Quick Facts Callout:
Details:
Fisetin is found in strawberries, apples, and onions. Animal studies suggest it reduces oxidative stress and inflammation while extending lifespan in some models. Human studies are still early. Compared with quercetin, fisetin shows stronger senolytic effects but has solubility challenges. Supplement protocols for senolytic use are under investigation.
What the Evidence Says:
Fisetin vs Quercetin:
Both are flavonoids, but fisetin has shown stronger senolytic effects in lab studies. Quercetin is more bioavailable, but fisetin is drawing interest for longevity research.
Safety:
Generally safe at dietary levels. Supplement dosing protocols for senolytic effects are still under investigation.
Calcium Alpha-Ketoglutarate (Ca-AKG)
What It Is:
Ca-AKG is a metabolite in the Krebs cycle, the body’s central energy-producing pathway. It plays roles in muscle recovery, nitrogen balance, and mitochondrial health.
Quick Facts Callout:
Details:
Ca-AKG supports energy production and nitrogen balance. Research suggests potential benefits for endurance, recovery, and markers of biological aging, though more human data are needed. Distinct from AAKG, which is used in sports supplements, Ca-AKG is the form studied in aging. Safe at 1–4 g/day depending on form, with GI tolerance as the main consideration.
What the Evidence Says:
Ca-AKG vs AAKG:
AAKG (arginine alpha-ketoglutarate) is common in sports supplements. Ca-AKG, however, is the form used in longevity research due to better stability and relevance to aging.
Safety:
Doses vary by form. GI tolerance is the main concern. Current human studies suggest good safety at typical doses.
Metformin
What It Is:
Metformin is a prescription biguanide widely used as the first-line treatment for type 2 diabetes. Because of its effects on glucose metabolism, insulin sensitivity, and cellular energy pathways, it has become one of the most studied drugs in aging research.
Quick Facts Callout:
Improves insulin sensitivity and lowers blood glucose.
Activates AMPK, a nutrient-sensing pathway linked to longevity.
(Source: Landmark reviews on metformin and aging biology)
Details:
Metformin reduces hepatic glucose production and enhances insulin sensitivity in muscle and fat. Beyond diabetes, epidemiologic studies suggest metformin users may have lower rates of cardiovascular disease, cancer, and mortality compared to non-users, though confounding factors remain. In longevity research, metformin is being evaluated in the TAME (Targeting Aging with Metformin) trial, the first large-scale study testing whether a drug can delay multiple age-related diseases simultaneously. Typical doses for diabetes are 500–2,000 mg/day, with extended-release versions improving tolerance.
What the Evidence Says:
Large clinical experience (millions of patients worldwide) supports its safety and metabolic benefits.
Observational studies suggest reduced incidence of some cancers and cardiovascular events in people taking metformin.
Animal and cellular studies show activation of AMPK and reduced oxidative stress, mechanisms that overlap with calorie restriction.
Dedicated anti-aging trials (e.g., TAME) are ongoing; results are not yet available.
Metformin vs Other AMPK Activators:
Unlike supplements that indirectly influence AMPK, metformin has decades of clinical safety data and remains the most widely used pharmacologic activator of this pathway.
Safety:
Metformin is prescription-only. The most common side effect is gastrointestinal upset (diarrhea, nausea, abdominal cramping), usually improved with slow titration or extended-release forms. It is contraindicated in advanced kidney disease due to the rare risk of lactic acidosis. Long-term use can lower vitamin B12 levels, so monitoring is recommended.